Calprotectin Technical News - BUHLMANN - Gastroenterology - IBD

Category: Calprotectin Technical News

The Advantages of an Immunoturbidimetric Assay for Measuring Calprotectin in Fecal Samples

 Technical Details Speed An immunoturbidimetric assay (or particle-enhanced turbidimetric immunoassay (PETIA)) for measuring Calprotectin is the fastest solution in the market with the shortest time to first result regardless of using sample batches or random access. On average, the time to first result is 7.6 min [5 min -11.6 min] with additional results every 10.86
Continue Reading

The Value of Calprotectin in Inflammatory Bowel Disease Management

Calprotectin: The Key to a Successful Treatment Pathway for IBD What is Inflammatory Bowel Disease? Inflammatory Bowel Disease (IBD) is a chronic inflammatory disease of the gut, which presents with periods of inflammatory activity (flares) and quiescent phases (remission) as  can be seen in many chronic diseases. IBD includes several different diseases; the two most
Continue Reading